Display options
Cite
Gin H, Rigalleau V, Perlemoine C. Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus. J Nutr Metab. 2009;2010doi: 10.1155/2010/340570.
Gin, H., Rigalleau, V., & Perlemoine, C. (2010). Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus. Journal of nutrition and metabolism, 2010. https://doi.org/10.1155/2010/340570
Gin, H, et al. "Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus." Journal of nutrition and metabolism vol. 2010 (2010). doi: https://doi.org/10.1155/2010/340570
Gin H, Rigalleau V, Perlemoine C. Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus. J Nutr Metab. 2010;2010. doi: 10.1155/2010/340570. Epub 2009 Oct 21. PMID: 20721344; PMCID: PMC2915774.
Copy Download .nbib Format: NLM
Share it on

J Nutr Metab. 2010;2010. doi: 10.1155/2010/340570. Epub 2009 Oct 21.

Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus.

Journal of nutrition and metabolism

H Gin, V Rigalleau, C Perlemoine

Affiliations

  1. UMR 5536 CNRS/Université de Bordeaux 2(Victor Segalen), 33000 Bordeaux, France.

PMID: 20721344 PMCID: PMC2915774 DOI: 10.1155/2010/340570

Abstract

Aims. To determine the progression of body weight (BW) and body composition (BC) in patients with type 2 diabetes mellitus (T2D) on insulin therapy and the consequences on muscle strength (MS) as a reflect of free fat mass increases. Research design and methods. We analysed BC using air displacement plethysmography and MS by hand grip dynamometry in 40 T2D before and after three (M3) and six months (M6) of insulin therapy. Results. at baseline HbA1c was 9.76 +/-1.6% and BW was stable with fat mass (FM) 28 +/- 10.7 kg; and fat free mass (FFM) 52.4 +/- 11 kg; at M6, HbA1c improved to 7.56 +/- 0.8%; insulin doses tended to increase. BW gain at M6 was + 3.2 +/- 4.2 kg and with an increase of only 25% by M3; it was composed of FM, whereas FFM was unchanged. MS did not increase on insulin therapy. Conclusions. In T2D, BW gain was composed exclusively of FM with no improvement in MS.

References

  1. J Gerontol A Biol Sci Med Sci. 2006 Feb;61(2):156-64 - PubMed
  2. Lancet. 1998 Sep 12;352(9131):837-53 - PubMed
  3. Diabetes Care. 2001 Oct;24(10):1711-21 - PubMed
  4. Diabet Med. 2004 Dec;21(12):1298-303 - PubMed
  5. Lancet. 1986 Aug 16;2(8503):360-4 - PubMed
  6. Diabetes Metab. 1999 Sep;25(4):321-8 - PubMed
  7. Adv Biol Med Phys. 1956;4:239-80 - PubMed
  8. FASEB J. 2004 Oct;18(13):1586-7 - PubMed
  9. Diabet Med. 1996 Jan;13(1):40-6 - PubMed
  10. J Nutr Health Aging. 2004;8(5):374-8 - PubMed
  11. Diabetes. 2002 Aug;51(8):2395-404 - PubMed
  12. Am J Clin Nutr. 2005 Aug;82(2):355-65 - PubMed
  13. Nutr Rev. 1991 Jun;49(6):163-75 - PubMed
  14. Eur J Clin Nutr. 1998 Jan;52(1):45-53 - PubMed
  15. Diabetologia. 2005 Feb;48(2):222-9 - PubMed
  16. J Nutr. 2006 May;136(5):1249-55 - PubMed
  17. J Nutr. 1998 Feb;128(2 Suppl):323S-327S - PubMed
  18. Br J Nutr. 2005 Dec;94(6):931-7 - PubMed
  19. Diabetes Res Clin Pract. 2005 Dec;70(3):278-86 - PubMed
  20. Am J Clin Nutr. 2002 Mar;75(3):453-67 - PubMed
  21. Obesity (Silver Spring). 2007 Jan;15(1):78-84 - PubMed
  22. BMJ. 2001 Mar 24;322(7288):716-20 - PubMed
  23. Diabetes Metab. 2006 Dec;32(6):643-8 - PubMed
  24. Int J Epidemiol. 2007 Feb;36(1):228-35 - PubMed
  25. Diabetes Obes Metab. 2001 Dec;3(6):410-6 - PubMed
  26. Med Sci Sports Exerc. 1995 Dec;27(12):1692-7 - PubMed
  27. Eur J Clin Nutr. 2007 Jan;61(1):25-9 - PubMed

Publication Types